Time filter

Source Type

Viby, Sweden

Arla Foods is a International cooperative based in Århus, Denmark, and the largest producer of dairy products in Scandinavia. Arla Foods was formed as the result of a merger between the Swedish dairy cooperative Arla and the Danish dairy company MD Foods on 17 April 2000.Arla Foods is the seventh largest dairy company in the world measured by turnover. Among the cooperative dairy companies Arla is the third largest in the world. At the start of 2010, 7,625 Danish and Swedish cooperative members owned the cooperative.Arla Foods has three major brands: Arla, Lurpak and Castello cheeses that are sold worldwide. The Arla Brand is both a co-operative brand and a brand across all product categories. The Lurpak brand of butter and spreads is owned by the Danish Dairy Board, and Castello is a cheese brand including blue cheese and yellow cheeses. The name Arla derives from the same word as the English word "early" and is an archaic Swedish term for "early ".Arla Foods incorporates Arla Foods Ingredients, a former division established as an independent subsidiary in 2011. The company develops and manufactures milk-based ingredients, primarily functional and nutritional milk proteins, bioactive phospholipids, minerals, permeate and lactose for the food industry. Head office is located in Denmark.Arla Foods Ingredients has one wholly owned production plant in Denmark, with joint venture production at facilities in Argentina and Germany. In early 2011, Arla Foods and DMK formed the joint venture company ArNoCo GmbH & Co. KG, to produce whey proteins for the food industry. Wikipedia.

The present invention pertains to a method of producing caseinomacropeptide (CMP)-containing compositions in high yield and having a very low content of phenylalanine (Phe). More specifically, the method involves subjecting a whey derived feed to a combination of ultrafiltration and subsequent cation exchange.

Forsyth Dental Infirmary For Children D B A The Forsyth Institute and Arla Foods | Date: 2013-07-19

The present invention relates to isolated, pharmaceutically active, osteopontin-related molecules, pharmaceutical compositions and nutritional supplements comprising such molecules, and use of such compositions and supplements for treating or preventing tumor-generating cancer.

The present invention relates to nanoparticle aggregates comprising osteopontin (OPN) and one or more particles containing calcium and/or strontium and to their use for reducing or preventing biofilm growth or for removing biofilm. The invention furthermore relates to the use of the nanoparticle aggregates for treating, alleviating or preventing biofilm-related diseases.

The present invention pertains to a method of producing beta-casein-containing compositions and products obtainable by such methods. More particularly, the invention pertains to a method of producing beta-casein compositions using controlled microfiltration first at a temperature higher than 20 degrees C., followed by cooling of the retentate to 0-15 degrees C. and a second microfiltration of the cooled composition resulting in beta-casein containing permeate.

Arla Foods | Date: 2013-07-24

Infant formula containing osteopontin and use of osteopontin as supplement for infant formulas or baby food.

Discover hidden collaborations